✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-023 min read

GLP-1 Medications and Breastfeeding: Is It Safe?

There is limited data, and the cautious, honest answer is to wait. Here is why.

An abstract sense of mental calm replacing busy clutter

The short answer

GLP-1 medications are generally not recommended while breastfeeding, because there is limited safety data and manufacturers advise against use during nursing. The cautious, honest position is to wait until you are no longer breastfeeding, and to make this decision with your physician.

Why the caution

It is not known with confidence how much, if any, of these medications passes into breast milk or how it might affect an infant, and rapid weight loss during nursing has its own considerations. With limited data on a vulnerable population, responsible clinicians default to caution rather than assuming safety.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

What to do instead for now

During breastfeeding, the focus is usually on nutrition, gentle activity, sleep where possible, and support, with medication revisited afterward. If you became pregnant or started nursing while on a GLP-1, tell your physician promptly so they can guide next steps. Do not start, stop, or adjust on your own.

How this relates to what we offer

Our $119 review screens for pregnancy and breastfeeding, and we do not start GLP-1 treatment during nursing. We will revisit a plan when it is appropriate and safe.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Can I take semaglutide while breastfeeding?

It is generally not recommended. There is limited safety data and manufacturers advise against GLP-1 use while nursing. The cautious approach is to wait and decide with your physician.

Does semaglutide pass into breast milk?

It is not known with confidence, which is part of why caution is advised. With limited data on infants, responsible clinicians default to not using it during breastfeeding.

I started a GLP-1 and then began breastfeeding. What now?

Tell your physician promptly. Do not adjust on your own; they will guide whether and how to pause and what to do next.

When can I restart after breastfeeding?

Once you are no longer nursing, your physician can reassess and restart a plan if appropriate. Timing is individualized to you.

Does New Hope screen for breastfeeding?

Yes. The $119 review screens for pregnancy and breastfeeding, and we do not start GLP-1 treatment while you are nursing.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.